Showing results (121-130 of 261) with videos related to
Sort By:
Pageof 27
Clinical Endocrinology|August 6, 1999
Life expectancy following surgery for pituitary tumoursA S Bates, B Bullivant, M C Sheppard, et al.Pituitary|November 18, 2000
The therapeutic value of somatostatin and its analoguesS Farooqi, J S Bevan, M C Sheppard, et al.Clinical Endocrinology|May 1, 1984
Measurement of free thyroxine and free triiodothyronine in asymptomatic subjects with high concentrations of serum TSH and a history of radioiodine therapyJ A Franklyn, M C Sheppard, D B Ramsden, et al.QJM : Monthly Journal of the Association of Physicians|April 1, 1995
Assessing the hypothalamo-pituitary-adrenal axis in patients on long-term glucocorticoid therapy: the short synacthen versus the insulin tolerance testK F Kane, P Emery, M C Sheppard, et al.Acta Endocrinologica|September 1, 1989
Effect of hypothyroidism and thyroid hormone treatment of the rat on hepatic Spot 14 and thyroxine binding prealbumin mRNAsJ A Franklyn, S King, J A Ahlquist, et al.Journal of Clinical Pathology|September 1, 1983
Recurrent insulinoma syndrome with metastatic glucagonomaP J Dunn, M C Sheppard, D A Heath, et al.South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|March 29, 1980
Failure of somatostatin to inhibit epinephrine (adrenaline)-stimulated hepatic glucose output in vitroB D Kramer, K Waligora, M C Sheppard, et al.Molecular and Cellular Endocrinology|December 1, 1984
The effects of growth factors and serum on DNA synthesis and differentiation in thyroid cells in cultureM C Eggo, L K Bachrach, G Fayet, et al.The Quarterly Journal of Medicine|December 1, 1987
Fine needle aspiration cytology in the management of euthyroid goitreJ A Franklyn, M G Fitzgerald, G D Oates, et al.Clinical Endocrinology|September 1, 1999
Increased MEN1 mRNA expression in sporadic pituitary tumoursC J McCabe, N J Gittoes, M C Sheppard, et al.Pageof 27